Classic galactosemia results from mutations in the galactose-1-phosphate uridyl transferase gene and causes infants to present with jaundice after initiation of lactose containing formulas. Jaundice associated with galactosemia is often thought to have a prominent direct fraction. We report an infant with galactosemia who presented with severe jaundice from indirect hyperbilirubinemia and met criteria for an exchange transfusion within 48 h after milk ingestion.
Introduction
Jaundice is a frequent problem encountered in the first few days after birth in both late preterm and term infants. 1 Jaundice in most newborns is indirect hyperbilirubinemia, benign in prognosis and usually represents an imbalance between bilirubin production and its metabolism (physiologic jaundice). 1, 2 For most newborns, these imbalances dissipate within 72 h and jaundice resolves. Indirect hyperbilirubinemia in the first postnatal day is often non-physiological. The differential diagnosis of indirect hyperbilirubinemia in the first postnatal day most commonly is a hemolytic process (for example, blood group incompatibility and less commonly erythrocyte enzyme and membrane defects). 3 This report describes an infant with galactosemia who manifested extreme indirect hyperbilirubinemia on the first postnatal day.
Case
Here, we report a case of a male child born at 39 weeks to an 18-year-old gravida 6 now para 1 mother at a Level 1 facility. The previous five pregnancies resulted in spontaneous abortions at 6 weeks gestation of unknown etiology. Maternal prenatal laboratory assessments were unremarkable and she was negative for Group B Streptococcus colonization. Past medical, surgical and family histories were noncontributory. An ultrasound at 17 weeks gestation was unremarkable and the pregnancy was uneventful.
Delivery occurred through a vacuum-assisted vaginal delivery after non-reassuring fetal heart tracings, 13 h of ruptured membranes and pitocin augmentation. The infant had poor respiratory effort, tone and color, and required positive pressure ventilation for 2 min. Apgar scores were 5, 7 and 9 at 1, 5 and 10 min, respectively, and the cord blood had a pH of 7.22 and base deficit of À7.2. Birth weight was 3040 g. The infant was triaged to the newborn nursery, and physical examination at 12 h of life was notable for caput succedaneum and normal growth parameters. At 31 h of life, extreme jaundice was noted, and total and direct (T/D) bilirubin levels were 22.1 and 0.6 mg per 100 ml. Phototherapy was initiated, and bilirubin levels were unchanged after 5 h of treatment. Activity was normal, feeding was poor (7 to 20 ml of formula per feed) and the infant was transferred to Women and Infants Hospital.
On admission, the infant's weight was 2865 g (5.8% below birth weight), and the exam was notable for stable vital signs, prominent jaundice, caput succedaneum, absent hepatosplenomegaly, and appropriate muscle tone, responsiveness and activity level. Laboratory evaluation at 39 h of age revealed T/D bilirubin levels of 22.8 and 0.8 mg per 100 ml, hematocrit of 48.6%, normal red cell morphology with occasional polychromasia, reticulocyte count of 8.6%, WBC of 14 200 mcl À1 with 63% neutrophils and 26% lymphocytes, and platelets of 272 000 mcl À1 . The infant's blood type was O positive, and negative for both the direct and indirect antibody testing. Cord blood T/D bilirubin concentrations were 1.9 and 0.3 mg per 100 ml. A blood culture was sent and was subsequently negative. Electrolytes were unremarkable except for blood urea nitrogen of 25 mg per 100 ml and a creatinine concentration of 1.0 mg per 100 ml.
The hospital course was characterized by a gradual rising bilirubin in spite of intensive phototherapy, supplemental intravenous fluid (135 ml kg À1 per day) and continued enteral intake with a lactose containing formula. At 57 h of life, the total bilirubin was 25 mg per 100 ml, and the infant underwent a double volume exchange transfusion. Serial bilirubin concentrations are plotted in Figure 1 .
At 68 h of life, the newborn screen obtained at the referring hospital was positive for galactosemia. The lactose containing formula was changed to a soy-based formula, and enteral intake improved. Galactose-1-phosphate uridyl transferase (GALT) activity was normal, reflecting donor blood. Galactose-1-phosphate content of the infant's red cells post exchange transfusion was 248 mg per g Hgb (normal range 5 to 29 mg per g Hgb), which was consistent with galactosemia. Genetic testing indicated a compound heterozygote genotype for two of the most common alleles for GALT deficiency, Q188R and L195P. 4 Ophthalmologic exam was negative for cataracts.
At hospital discharge, T/D bilirubin levels were 5.9 and 0.4 mg per 100 ml, weight was 2670 g, enteral intake was good and hearing evaluations (both the otoacoustic emission test and the automated auditory brainstem responses test) were normal. He has been followed in the Metabolism Clinic and is stable on a galactose-restricted diet.
Discussion
This case illustrates that severe indirect hyperbilirubinemia can be a manifestation of galactosemia soon after birth. More frequent etiologies for indirect hyperbilirubinemia, such as blood group incompatibility and red cell membrane defects, were excluded by antibody testing and a peripheral blood smear. Red cell enzyme defects were not investigated once the diagnosis of galactosemia was established. The infant was feeding poorly from birth and suggested an enhanced enterohepatic circulation contributing to the indirect hyperbilirubinemia. However, the elevated reticulocyte count and cord bilirubin suggest an etiology involving rapid red cell turnover, and in retrospect, the poor feeding likely reflects galactosemia. 5 Galactosemia is interestingly missing in the differential of indirect hyperbilirubinemia in major neonatal references. 6, 7 Galactosemia results from deficiencies of one of three enzymes, GALT, galactokinase or uridine diphosphate galactose 4-epimerase. 5 GALT deficiency is the most common and severe form of galactosemia, and is generally given the term 'classic galactosemia'. 5, 8 It is an autosomal recessive disorder with more than 150 disease-causing mutations of the GALT gene located on chromosome 9p13. 8 The estimated incidence in the United States is approximately 1 in 40 000 to 60 000. 9 Classic galactosemia manifests in neonates with vomiting, diarrhea, jaundice, hepatomegaly, ascites and/or Escherichia coli sepsis within a few days after starting milk ingestion.
5,10 Prevention of death or permanent neurological sequelae is dependent on early diagnosis and institution of appropriate therapy. 10 Although galactosemia is universally screened as mandated by law in each state of the United States, 11 affected neonates often become ill before results are available. 10 The infant in this report presented with poor feeding and severe indirect hyperbilirubinemia soon after birth.
In multiple neonatal references, hyperbilirubinemia associated with galactosemia in the neonate and young infant is stated to be predominantly of the direct-reacting (conjugated) type, 6, 7, 12 suggesting a hepatic origin. 12 Galactosemia is listed as an etiology of conjugated hyperbilirubinemia from inherited/metabolic processes, 12, 13 which may become evident during the first week of life. 10 Other references are ambiguous about the type of hyperbilirubinemia associated with galactosemia. 5 More recent observations indicate that early hyperbilirubinemia of galactosemia may be predominantly unconjugated, 10, 14 and can become conjugated. 13 A hepatic origin is still plausible, as bilirubin conjugation may be inhibited by galactose-1-phosphate or other toxic metabolites that accumulate in galactosemia. The initial presentation of indirect hyperbilirubinemia may result from hemolysis. 10, 14 The exact mechanism for the hemolytic process is unclear and postulated to reflect red cell accumulation of galactose-1-phosphate. 10, 14, 15 Accumulation of galactose-1-phosphate within the red blood cell interferes with red cell oxygen consumption, adenosine triphosphate synthesis and breakdown, and the maintenance of other phosphate intermediates of glycolysis. 15, 16 One other proposed mechanism that may be very significant is the involvement of galactose-1-phosphate in a futile phosphorylation cycle in which ATP is trapped in galactose-1-phosphate, which may be dephosphorylated to metabolites that have no energy-generating capability, 14 resulting in early erythrocyte death. This may account for the elevated cord bilirubin and reticulocyte count.
This case report shows an association between galactosemia and early indirect hyperbilirubinemia that is severe enough to meet criteria for an exchange transfusion within 48 h after milk ingestion. Although uncommon, galactosemia should be considered in infants with unexplained early indirect hyperbilirubinemia.
